July 2, 2021
Mitsubishi Tanabe Pharma has launched Exservan (riluzole), an oral film formulation of riluzole for the treatment of amyotrophic lateral sclerosis (ALS), in the US through its local subsidiary. The company obtained the US commercial rights to the drug in January...read more